ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

Basic & Clinical Pharmacology & Toxicology

Basic & Clinical Pharmacology & Toxicology

Volume 102 Issue 2, Pages 90 - 93

Published Online: 22 Jan 2008

Journal compilation © 2010 Nordic Pharmacological Society


Published on behalf of the Nordic Pharmacological Society and the preferred publication of the European Association for Clinical Pharmacology and Therapeutics
Nordic Pharmacological Societies
Go to Society Site


< Previous Abstract  |  Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: HTML, PDF (Size: 114K)  | Related Articles | Citation Tracking

MiniReview
Developmental Origins of Health and Disease: New Insights
Mark A. Hanson 1 and Peter D. Gluckman 2
  1 Division of Developmental Origins of Health & Disease, University of Southampton, Southampton, UK , and   2 Liggins Institute, University of Auckland, Auckland, New Zealand
Author for correspondence: Mark A. Hanson, Developmental Origins of Health & Disease Division, Institute of Developmental Sciences, Mailpoint 887, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UK (fax +44 (0)23 8079 5255, e-mail m.hanson@soton.ac.uk).
Copyright Journal compilation © 2008 Nordic Pharmacological Society

ABSTRACT

Abstract: Epidemiological and animal studies show that small changes in the developmental environment can induce phenotypic changes affecting an individual's responses to their later environment. These may alter the risk of chronic disease such as metabolic syndrome or cardiovascular disease. Recent research shows that animals exposed to such a mismatch between prenatal and postnatal environment develop obesity, reduced activity, leptin and insulin resistance, elevated blood pressure and vascular endothelial dysfunction. Epigenetic processes are involved in such effects, targeted to promoter regions of specific genes in specific tissues. Such fine control of gene expression suggests that the mechanisms have been retained through evolution through their adaptive advantage, rather than representing extreme effects of developmental disruption akin to teratogenesis. There may be adaptive advantage in a developmental cue inducing a phenotypic change in generations beyond the immediate pregnancy, and a range of data that support this concept. In animals, epigenetic effects such as DNA methylation can be passed to successive generations. Environmental toxins, including endocrine disruptors, may induce greater risk of chronic disease, even at low exposure levels, if they affect such normal developmental epigenetic processes. Appropriate interventions may have long-term multigenerational effects to reduce the risk of chronic disease.


(Received May 18, 2007; Accepted October 1, 2007).

DIGITAL OBJECT IDENTIFIER (DOI)
10.1111/j.1742-7843.2007.00186.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member


Sign Up Now
Sign Up Now